SI221 is a pyrazolo-pyrimidine derivative which exerts inhibitory effects on Yes (a member of SFKs) which is overexpressed in rhabdomyosarcoma, thus reducing proliferation of cancer cells (Bagella and Marchesi, 2016). This evidence concerns the gene YES1 and cancer.